Correlation Between Consolidated Construction and Rossari Biotech

Can any of the company-specific risk be diversified away by investing in both Consolidated Construction and Rossari Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Consolidated Construction and Rossari Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Consolidated Construction Consortium and Rossari Biotech Limited, you can compare the effects of market volatilities on Consolidated Construction and Rossari Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Consolidated Construction with a short position of Rossari Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Consolidated Construction and Rossari Biotech.

Diversification Opportunities for Consolidated Construction and Rossari Biotech

0.68

Correlation Coefficient

Consolidated Construction  Rossari Biotech

Poor diversification

The 3 months correlation between Consolidated and Rossari is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Consolidated Construction Cons and Rossari Biotech Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rossari Biotech and Consolidated Construction is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Consolidated Construction Consortium are associated (or correlated) with Rossari Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rossari Biotech has no effect on the direction of Consolidated Construction i.e., Consolidated Construction and Rossari Biotech go up and down completely randomly.

Pair Corralation between Consolidated Construction and Rossari Biotech

Assuming the 90 days trading horizon Consolidated Construction Consortium is expected to under-perform the Rossari Biotech. In addition to that, Consolidated Construction is 1.43 times more volatile than Rossari Biotech Limited. It trades about -0.07 of its total potential returns per unit of risk. Rossari Biotech Limited is currently generating about -0.07 per unit of volatility. If you would invest  90,880  in Rossari Biotech Limited on September 18, 2024 and sell it today you would lose (8,965) from holding Rossari Biotech Limited or give up 9.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Consolidated Construction Cons  vs.  Rossari Biotech Limited

Consolidated Construction

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Consolidated Construction Consortium has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Rossari Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rossari Biotech Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Stock's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the firm traders.

Pair Trading with Consolidated Construction and Rossari Biotech

The main advantage of trading using opposite Consolidated Construction and Rossari Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Consolidated Construction position performs unexpectedly, Rossari Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rossari Biotech will offset losses from the drop in Rossari Biotech's long position.

The idea behind Consolidated Construction Consortium and Rossari Biotech Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.